FDA committee recommends flu shot composition for 2027-2028 season
Original framing: “Make next year’s flu shots, says FDA committee” — STAT News
It foregrounds the scientific backbone of vaccine composition—global viral tracking, antigenic mapping, and predictive modeling—while also exposing the limitations of current algorithms. The scientific dimension is strong but constrained by data gaps and industry influence.
The FDA committee's flu‑shot recommendation sits at the intersection of scientific rigor, historical precedent, and systemic inequities.
While robust surveillance and modeling underpin the decision, the exclusion of Indigenous insights and marginalized voices narrows its perspective, and corporate influence introduces a trickster paradox that threatens public trust. By weaving together equitable data sharing, independent modeling, participatory oversight, and traditional knowledge, a more resilient and inclusive vaccine ecosystem can emerge, better prepared for the uncertainties of future influenza seasons.